Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cyclezyme ABXSAT:CYCLE -15.16%8 EV-to-EBITDA is -45.01 as of Sep. 01, 2026. GuruFocus rates XSAT:CYCLE with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 1,341 Chemicals companies, Cyclezyme AB ranks worse than 74571.14% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cyclezyme AB's enterprise value is kr88.39 Mil.
Cyclezyme AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-1.96 Mil. Therefore, Cyclezyme AB's EV-to-EBITDA for today is -45.01.
The historical rank and industry rank for Cyclezyme AB's EV-to-EBITDA or its related term are showing as below:
XSAT:CYCLE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -57.12 Med: -21.5 Max: -15.45
Current: -45.01
During the past 6 years, the highest EV-to-EBITDA of Cyclezyme AB was -15.45. The lowest was -57.12. And the median was -21.50.
XSAT:CYCLE's EV-to-EBITDA is ranked worse than 100% of 1341
companies
in the Chemicals industry
Industry Median: 12.38
vs XSAT:CYCLE: -45.01
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Cyclezyme AB (XSAT:CYCLE) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cyclezyme AB's PE Ratio (TTM) for today is calculated as:
Cyclezyme AB's share price for today is kr31.90.
Cyclezyme AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.822.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Cyclezyme AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:CYCLE vs LIN, SHW, ECL: EV-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Cyclezyme AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyclezyme AB EV-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cyclezyme AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cyclezyme AB's EV-to-EBITDA falls into.
Cyclezyme AB's current Enterprise Value is kr88.39 Mil.
Cyclezyme AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cyclezyme AB (XSAT:CYCLE) has a EV-to-EBITDA of -45.01 as of Sep. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cyclezyme AB. According to the industry distribution chart, Cyclezyme AB ranks #999999 out of 1341 companies in the Chemicals industry.
Is Cyclezyme AB's EV-to-EBITDA too high?
Cyclezyme AB's current EV-to-EBITDA is -45.01. Based on the distribution chart, Cyclezyme AB ranks #999999 out of 1341 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Cyclezyme AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's EV-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Cyclezyme AB ranks #999999 out of 1341 companies for EV-to-EBITDA. This places Cyclezyme AB in the lower half of its industry. The industry median EV-to-EBITDA is 12.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Chemicals company?
The median EV-to-EBITDA among Chemicals companies is 12.38, based on 1,341 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Cyclezyme AB. For the Chemicals industry, the median EV-to-EBITDA is 12.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyclezyme AB's current EV-to-EBITDA is -45.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current EV-to-EBITDA of -45.01. The current EV-to-EBITDA is -45.01. Cyclezyme AB's overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current EV-to-EBITDA is -45.01 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
8GF Score
Get the complete analysis for XSAT:CYCLE
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CYCLE has been successfully added to your 
